FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website



Please select your country. This will keep you up to date with your country-specific information.

The perfect FIT – no matter your workload

FOB Gold scalable solutions

FIT, a faecal immunological test used for CRC screening, detects small amounts of blood invisible to the naked eye in stool samples by using antibodies specific to human haemoglobin. FIT does not require any diet restrictions and only takes a single sample collection procedure. The FIT test’s specificity for haemoglobin and ease of use make it analytically and clinically superior to other faecal occult blood tests (FOBT).

The FIT-based screening test is non-invasive, easy to perform and reliable, and manages to attract high participation rates – the main driver behind the success of any screening programme.

Generally, national or regional governmental administrations assume responsibility for implementing the population-based and organised screening programmes, managing their logistics, financials and efficiency in close cooperation with selected partners, such as the laboratories that provide the FIT test results.

Our customer-centric approach focuses on laboratories’ main challenges of processing samples quickly and cost efficiently while maintaining a standardised, high analytical quality. We are experienced in collaborating with national and regional organisations, and with laboratories to address and solve these challenges.

We provide unique FIT testing solutions for screening both asymptomatic populations (use of FIT as rule-in testing) and symptomatic patients (using FIT as rule-out testing).
The unique features of our universal FOBGold assay tubes make our FIT test suitable for the widest possible range of lab settings and clinical needs. We offer two versions of the FOB Gold tube: open and pierceable.

You can place the FOB Gold pierce tube on the stand-alone faecal analyser SENTiFIT 270 or, for high-throughput needs, on a total laboratory automation (TLA) solution offering walk-away operation.

The FOB Gold open tube can be placed on the majority of clinical chemistry analysers existing in routine labs, offering you maximum flexibility.

„You can easily analyse a few thousands tests per day.“

Wolfert Spijker, CEO Organisation for Population Screening in the Netherlands

Read interview

Why is FIT the preferred screening test?

More information on FIT for CRC Screening

How can we help you?

Watch video
To our video
Watch our video